Cargando…
A Systemic Review and Experts’ Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder
Bipolar disorder (BD) is a major psychiatric disorder that is easily misdiagnosed. Patient adherence to a treatment regimen is of utmost importance for successful outcomes in BD. Several trials of antipsychotics suggested that depot antipsychotics, including long-acting first- and second-generation...
Autores principales: | Chou, Yuan Hwa, Chu, Po-Chung, Wu, Szu-Wei, Lee, Jen-Chin, Lee, Yi-Hsuan, Sun, I-Wen, Chang, Chen-Lin, Huang, Chien-Liang, Liu, I-Chao, Tsai, Chia-Fen, Yen, Yung-Chieh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540044/ https://www.ncbi.nlm.nih.gov/pubmed/26243837 http://dx.doi.org/10.9758/cpn.2015.13.2.121 |
Ejemplares similares
-
Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2
por: Sajatovic, Martha, et al.
Publicado: (2018) -
Taiwan Expert Consensus Recommendations for Switching to Aripiprazole Long-Acting Once-Monthly in Patients with Schizophrenia
por: Liang, Chih-Sung, et al.
Publicado: (2021) -
Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics – expert consensus survey part 1
por: Sajatovic, Martha, et al.
Publicado: (2018) -
Pharmacological management of bipolar disorder: Japanese expert consensus
por: Sakurai, Hitoshi, et al.
Publicado: (2020) -
Long Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Bipolar Disorder
por: DEVRİMCİ ÖZGÜVEN, Halise, et al.
Publicado: (2021)